Nualtis Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
33
- Latest Deal Type
-
M&A
- Financing Rounds
-
14
- Investments
-
1
Nualtis General Information
Description
Manufacturer of oral thin-film drug delivery systems intended to improve pharmaceutical care. The company's technology includes proprietary human and veterinary film platforms, providing contract development, GMP manufacturing, and regulatory support to pharmaceutical partners for the creation of rapid-dissolve therapeutic solutions.
Contact Information
Website
www.nualtis.com(Operating Subsidiary)
Corporate Office
- 6420 Rue Abrams
- Saint-Laurent, Quebec H4S 1Y2
- Canada
Corporate Office
- 6420 Rue Abrams
- Saint-Laurent, Quebec H4S 1Y2
- Canada
Nualtis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nualtis Comparisons
Industry
Financing
Details
Nualtis Competitors (18)
One of Nualtis’s 18 competitors is Lts - Lohmann Therapy Systems, a Corporation company based in Caldwell, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lts - Lohmann Therapy Systems | Corporation | Caldwell, NJ | ||||
| BioDelivery Sciences International | Private Equity-Backed | Raleigh, NC | ||||
| Haofeng Biotechnology | Venture Capital-Backed | Taipei, Taiwan | ||||
| Oramed Pharmaceuticals | Corporation | New York, NY | ||||
| Oncimmune | Formerly VC-backed | Cambridge, MA |
Nualtis Signals
Nualtis Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nualtis Investments (1)
Nualtis’s most recent deal was a Corporate with Pillar5 Pharma. The deal was made on 03-May-2010.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Pillar5 Pharma | 03-May-2010 | Corporate | BPO/Outsource Services |
Nualtis Exits (1)
Nualtis’s most recent exit was on 03-May-2010 from Pillar5 Pharma. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Pillar5 Pharma | 03-May-2010 | Completed |
|
Nualtis FAQs
-
When was Nualtis founded?
Nualtis was founded in 2003.
-
Where is Nualtis headquartered?
Nualtis is headquartered in Saint-Laurent, Canada.
-
What is the size of Nualtis?
Nualtis has 33 total employees.
-
What industry is Nualtis in?
Nualtis’s primary industry is Drug Delivery.
-
Is Nualtis a private or public company?
Nualtis is a Private company.
-
What is the current valuation of Nualtis?
The current valuation of Nualtis is .
-
What is Nualtis’s current revenue?
The current revenue for Nualtis is .
-
How much funding has Nualtis raised over time?
Nualtis has raised $51.9M.
-
Who are Nualtis’s investors?
AtaiBeckley and Tilray Brands have invested in Nualtis.
-
Who are Nualtis’s competitors?
Lts - Lohmann Therapy Systems, BioDelivery Sciences International, Haofeng Biotechnology, Oramed Pharmaceuticals, and Oncimmune are some of the 18 competitors of Nualtis.
-
When was Nualtis acquired?
Nualtis was acquired on 10-Sep-2026.
-
Who acquired Nualtis?
Nualtis was acquired by COSCIENS Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process